<scp>MYC</scp> and therapy resistance in cancer: risks and opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MYC and therapy resistance in cancer: risks and opportunities

Published:2022-10-20 Issue:21 Volume:16 Page:3828-3854
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Donati Giulio¹^ORCID,Amati Bruno¹^ORCID

Affiliation:

1. European Institute of Oncology (IEO) – IRCCS Milan Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13319

Reference315 articles.

1. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis

2. Basic helix-loop-helix transcription factor gene family phylogenetics and nomenclature

3. Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc

4. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bufalin: A promising therapeutic drug against the cisplatin-resistance of ovarian cancer by targeting the USP36/c-Myc axis;Biochemical and Biophysical Research Communications;2024-11

2. A 15-Gene prognostic signature with TFAP2B functioning in Platinum Resistance of Ovarian Carcinoma;2024-09-09

3. Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer;Current Cancer Drug Targets;2024-09

4. Enhanced anticancer activity of N,N-bis(5-ethyl-2-hydroxybenzyl)methylamine (EMD) hydrophobic drug encapsulated in β-cyclodextrin nanosponges;Colloid and Interface Science Communications;2024-09

5. A common druggable signature of oncogenic c-Myc, mutant KRAS and mutant p53 reveals functional redundancy and competition among oncogenes in cancer;Cell Death & Disease;2024-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3